top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation
Philadelphia, December 4, 2024 (PRNewswire) -- Dr. Vatsala Naageshwaran, an accomplished biopharmaceutical leader, has been appointed...
SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments
South San Francisco, CA, December 18, 2024 (Business Wire) -- SiteOne Therapeutics has raised $100 million in Series C funding to...
Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth
San Diego, CA, December 12, 2024 (Business Wire) -- Pleno, Inc., a clinical and multi-omics diagnostics company, has appointed Dr. Vik...
AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform
North Chicago, IL and Madison, WI, December 13, 2024 (PRNewswire) -- AbbVie will acquire Nimble Therapeutics, gaining its lead oral...
Coherus Divests UDENYCA Franchise to Intas in $558.4M Deal to Fund Immuno-Oncology Expansion
Redwood City, CA, December 3, 2024 (Globe Newswire) -- Coherus is selling its UDENYCA franchise to Intas Pharmaceuticals for up to...
COUR Pharmaceuticals Secures $40M Upfront in Genentech Deal, Potential Milestones Exceed $900M
Chicago, December 3, 2024 (Globe Newswire) -- COUR Pharmaceuticals and Genentech have partnered to develop novel autoimmune disease...
BioFuse Medical Technologies Appoints Rick Early as CEO
Tampa, FL, December 4, 2024 (AccessWire) -- BioFuse Medical Technologies has announced significant leadership updates, appointing Rick...
Velentium Appoints Matt Hanks as CEO, Co-Founder Dan Purvis Named Board Chair to Propel Growth
Houston, TX, December 2, 2024 ( Business Wire ) -- Velentium has announced a leadership transition to support its continued growth,...
Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough
Warren, NJ, December 2, 2024 (Reuters) -- Novartis is acquiring PTC Therapeutics' Huntington’s disease drug, PTC518, for up to $2.9...
Zenflow Secures $24M in Sercies C- Funding
South San Francisco, CA, November 18, 2024 (Globe Newswire) -- Zenflow, Inc., a leader in medical device innovation for urological...
Nobias Therapeutics Appoints Patrick Dougherty as CEO to Lead Next Phase of Growth
Philadelphia, November 14, 2024 (PRNewswire) -- Nobias Therapeutics has named Patrick Dougherty as its Chief Executive Officer, marking...
Metsera Secures $215M in Series B Funding to Advance Obesity and Metabolic Disease Portfolio
New York, November 13, 2024 (Business Wire) -- Metsera has raised $215 million in Series B financing, led by Wellington Management and...
Julie Eastland Appointed CEO of Zentalis Pharmaceuticals to Lead Advancement of Azenosertib in Oncology
San Diego, CA, November 13, 2024 (Globe Newswire) -- Zentalis Pharmaceuticals has appointed Julie Eastland as CEO, supported by Ingmar...
Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio
Marlborough, MA, November 15, 2024 (PRNewswire) -- Boston Scientific has acquired Axonics for $3.7 billion, expanding its Urology...
Axonis Therapeutics Secures $115M Series A to Advance Neuromedicine Pipeline
Boston, MA, October 30, 2024 (PRNewswire) -- Axonis Therapeutics raised $115 million in Series A funding to advance AXN-027 for...
Celltex Therapeutics Welcomes Anita Perry as CEO
Houston, TX, November 5, 2024 (PRNewswire) -- Celltex Therapeutics appointed Anita Perry as CEO following the retirement of Co-Founder...
Alpha-9 Oncology Secures $175M Series C to Drive Radiopharmaceutical Innovation in Cancer Treatment
Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to...
I-Mab Appoints Dr. Sean Fu as Permanent CEO to Lead Advancement of Cancer Immunotherapy Programs
Rockville, MD, November 6, 2024 (PRNewswire) -- I-Mab has named Dr. Sean Fu as its CEO to drive forward its cancer immunotherapy...
AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio
North Chicago, IL, October 28, 2024 (Reuters) -- AbbVie will acquire Aliada Therapeutics for $1.4 billion to gain access to an...
Terray Therapeutics Secures $120M in Series B Funding to Revolutionize Small Molecule Drug Development with Advanced AI
Los Angeles, CA, October 17, 2024 (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to...
bottom of page